InvestorBrandNetwork (IBN) Content Platform

Brain Scientific (OTCQB: BRSF), a Florida-based applied science technology company, has announced a new distribution agreement with MVAP Medical Supplies to pursue the rapidly growing and underserved pediatric EEG marketplace. According to the announcement, MVAP Medical Supplies, an industry leader in the sleep, EEG, EMG, IOM, respiratory and patient care supplies space, will help Brain Scientific further expand its sales and distribution network to key growth markets. “We designed the NeuroCap to be game-changing in the neurodiagnostic wearable space. It has critical applications in pediatrics, emergency and ICUs, at-home care and research,” said Hassan Kotob, CEO of Brain Scientific. “We are excited to have MVAP Medical Supplies with us on our journey to becoming the leading medical wearables provider on the planet.”

To view the full press release, visit https://ibn.fm/MAg7t

About Brain Scientific Inc.

Brain Scientific is an applied sciences technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of medical and OEM devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap(TM) and NeuroEEG(TM) are smart neurological diagnostic devices that simplify administration, shorten scan time and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of OEM devices. To learn more about Brain Scientific’s corporate strategy, products or investor relations, please visit www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company has announced that the Safety Review Committee (“SRC”) approved continuation to the third and final cohort in the dose escalation Phase 1 portion of the Acclaim-1 Phase 1/2 clinical trial of REQORSA(R) in combination with Tagrisso(R) (osimertinib) to treat late-stage non-small cell lung cancer (“NSCLC”). In 2020, the REQORSA/osimertinib combination received U.S. Food and Drug Administration’s (“FDA”) Fast Track Designation for treatment of the Acclaim-1 patient population. “The SRC’s recommendation to increase the dosing of REQORSA is further confirmation of its favorable safety profile and it enables us to advance Acclaim-1 into the final cohort of the Phase 1 dose escalation portion of the study,” said Genprex Chief Medical Officer Mark Berger, M.D. “We look forward to completing enrollment of this final cohort in the first quarter of 2023.”

In addition, the company today announced its entry into a license agreement with the University of Pittsburgh. The agreement grants Genprex a worldwide, exclusive license to certain patent applications and related technology and a worldwide, non-exclusive license to use certain related know-how, all related to modulating autoimmunity in type 1 diabetes by using gene therapy. “Gaining exclusive access to technology that modulates the immune system by transforming macrophages could prove to be significant to our broader research partnership with the laboratory of George Gittes, MD, Professor of Surgery and Pediatrics and Chief of the Division of Pediatric Surgery at the University of Pittsburgh School of Medicine,” Genprex CMO Dr. Berger said in the news release. “We are making significant strides in our program with Dr. Gittes’s innovative approach to treating diabetes by the transformation of alpha cells into beta-like cells and are excited to add to our arsenal this additional technology also out of Dr. Gittes’s lab, in collaboration with the laboratory of Dr. Xangwei Xiao, Assistant Professor of Surgery, also in the Division of Pediatric Surgery at the University of Pittsburgh’s School of Medicine. Not only could this new approach be used to reduce autoimmune activity in type 1 diabetes by modulating the immune system, but potentially it could also work in conjunction with the technology we have licensed previously.”

To view the full press releases, visit https://ibn.fm/XQsLz and https://ibn.fm/lOqaT

About Genprex Inc.

Genprex is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, non-viral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic gene therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is then taken up by tumor cells that express tumor suppressor proteins that are deficient in the body. The company’s lead product candidate, REQORSA(TM) (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”) (with each of these clinical programs receiving a Fast Track Designation from the Food and Drug Administration) and for small cell lung cancer. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an endoscope and an adeno-associated virus (“AAV”) vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of type 1 diabetes, the genes express proteins that transform alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system. In type 2 diabetes, where autoimmunity is not at play, it is believed that exhausted beta cells are also rejuvenated and replenished. For more information, visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Zauben, known for its Model Z living wall concept, attended the 5th Annual Sustainability Private Capital Event on December 7-8, 2022. The event was jointly hosted by Sustain SoCal and Roth Capital Partners. Venture capitalists and investors from private equity, family offices, endowments, foundations and angels attended the conference. This two-day virtual event offered a mammoth networking and business opportunity to connect with C-level executives with established private sustainability companies, mostly series A/B, in the solar/storage, e-mobility, Smart City, circular economy and water verticals. 

Winner of several prestigious awards for sustainability and innovation, Zuben’s premier product, Model Z living wall, allows businesses, organizations, and anyone to bring the beauty and benefits of outdoor greenery indoors, without worrying about maintenance. Their system incorporates…

Read More>>

To learn more about the conference, please visit https://ibn.fm/0AUAF & https://ibn.fm/YBuOk.
To learn more about Zauben, please visit (https://www.zauben.com/).

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) has appointed two financial advisors: Deutsche Bank Securities Inc. and Scotiabank. The two banks will serve as financial advisors for the equity component of the project financing for CNIKF’s Crawford Nickel Sulphide Project. According to the announcement, Canada Nickel has been “engaged in discussions” for the past 18 months as it has worked to identify financial advisors. The feasibility study on the Sulphide Project is nearing completion, and the company’s next priorities are project financing and permitting activities to ensure that financing is in place in a timely manner. Deutsche Bank and Scotiabank will provide invaluable assistance in this process, including the evaluation of strategic and financial alternatives for the equity portion of the project financing as well defense advisory and planning. Canada Nickel noted that it is also working on engaging an advisor for the debt portion of the project financing in early 2023. “As we move into the next phase of advancing Crawford towards production, we are pleased to engage two of the world’s leading investment banks with a broad base of mining and industrial expertise, Scotiabank and Deutsche Bank, to advise the Company on alternatives for the equity portion of the project financing for Crawford,” said Canada Nickel chair and CEO Mark Selby in the press release. “We are also pleased to announce that our team has completed another significant permitting milestone on the critical path towards production, by filing the detailed project description with the Impact Assessment Agency of Canada earlier this week. We continue to target receipt of permits by mid-2025 with construction to immediately follow.”

To view the full release, visit https://ibn.fm/4MEmC

About Canada Nickel Company

Canada Nickel is advancing the next generation of nickel-sulphide projects to deliver nickel required to feed the high-growth electric vehicle and stainless steel markets. Canada Nickel has applied in multiple jurisdictions to trademark the terms NetZero Nickel(TM), NetZero Cobalt(TM) and NetZero Iron(TM), and is also pursuing the development of processes to allow the production of net zero carbon nickel, cobalt and iron products. The company provides investors with leverage to nickel in low political risk jurisdictions. Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulphide Project in the heart of the prolific Timmins-Cochrane mining camp. For more information about the company, visit www.CanadaNickel.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, announced a new strategic medical billing partnership with Nexus Dental Systems. According to the announcement, Vivos anticipates that the partnership will generate new revenue immediately and will enable the two companies, which currently operate independent billing platforms, to create one of the most comprehensive medical billing services in the dental industry. The new alliance will offer greater access to both in or out-of-network billing with all major medical insurance companies as well as facilitate enhanced case acceptances and insurance billing procedures and reimbursement. “For a long time, medical billing has been a barrier to wide acceptance of dental offices treating breathing and sleep disorders, which is why we have historically offered fee-based out-of-network claims assistance to Vivos providers and their patients,” said Vivos Therapeutics chair and CEO Kirk Huntsman in the press release. “Our Billing Intelligence Service currently achieves a 98% success rate for reimbursement on out-of-network oral appliance claims, which is extremely high. This new relationship will now give Vivos-trained dentists immediate access to some of the highest in-network reimbursement rates in the industry, allowing higher case acceptance for Vivos-trained providers. We believe this will create immediate additional revenue opportunities, not only for Vivos but for providers within each network, while patients pay less out-of-pocket expenses.”

To view the full press release, visit https://ibn.fm/2jaoh

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution. It has proven effective in the treatment of an estimated 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Event agenda for kick-off event included special announcements, new releases, trainings, giveaways and more
• Hapi Travel is a membership-based travel club designed for maximum savings on the most luxurious vacation getaways throughout the world
• Post-COVID, people are ready to experience new locations and revisit places they love

The inaugural event for Hapi Travel Destinations recently wrapped up in Dallas, introducing the traveling world to a whole new approach to travel savings as well as a unique opportunity for those looking for additional income in the gig economy. A wholly owned subsidiary of Sharing Services Global (OTCQB: SHRG), Hapi Travel Destinations is a global leader in fun-filled, one-of-a-kind travel and offers exclusive travel-club membership.

The first-ever national travel event for Hapi Travel took place Nov. 11–12, 2022, and was designed to launch Hapi Travel. The event agenda included special announcements, new releases, trainings…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• Brian Haugli, with extensive experience in the field of cybersecurity, having led key programs for the Department of Defense, the Pentagon, and Fortune 500 companies, discusses the growing cybersecurity needs of small business, and the new technologies that now make such security far more accessible and affordable
• SMBs face, on average, 11 cyberthreats a day, with over 70% of SMBs facing cyberattacks, and 60% being put of business within six months after an attack
• SideChannel vCISOs (Virtual Chief Information Security Officers) make the highest quality cybersecurity expertise available for significantly less than the cost of a full-time CISO, representing 400-plus years of experience in cybersecurity and a bespoke cybersecurity program perfectly sized for growing enterprises

The cybersecurity market revenue is projected to reach over $156 billion in 2022, driven by the increased need for solutions that protect companies from threats of malware, ransomware, and vulnerabilities that let malicious characters infiltrate critical systems. This revenue is expected to grow at a CAGR of 10.92%, resulting in a value of over $262 billion by 2027 (https://ibn.fm/wE6KB). On the Cloud Security Reinvented with Andy Ellis podcast (https://ibn.fm/KV6vv), Ellis talks with Brian Haugli, managing partner and CEO at SideChannel (OTCQB: SDCH). In the episode titled “How to Let Go of the ‘Gotcha’ Mentality in Security with Brian Haugli,”  Haugli and Ellis discuss the necessity for cybersecurity and how small-to-mid-market companies are in need of solutions to accommodate the increased threats to technological systems.

According to Haugli, there are hundreds of thousands of companies, outside the Fortune 2000, that require diligence on what their security program looks like, and the question is always who can lead such an assessment and whether they can afford it. “The market is actually very hot when it comes to…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Amesite (NASDAQ: AMST) is a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets. The company today announced that it has submitted a response to the National Institute of Standards and Technology’s (“NIST”) request for information (“RFI”) regarding the design of potential semiconductor and microelectronics innovation manufacturing institutes in the United States. The Creating Helpful Incentives to Produce Semiconductors (“CHIPS”) for America Act is set to offer an array of supportive funding mechanisms to transform the U.S. semiconductor industry. On the heels of a recent collaboration with NAFEO, Amesite stands ready to help fulfil the talent shortages and diversity challenges the semiconductor industry faces today. “Amesite and NAFEO have the ability to launch sophisticated technological programs in as little as 24 hours around the globe, and are targeting funding for HBCUs and PBIs, to improve the diversity of the semiconductor workforce,” said Amesite CEO and Founder, Dr. Ann Marie Sastry. “The U.S. semiconductor urgently needs to upskill and reach diverse talent – and the best way to do that is to leverage a proven SaaS partnership. We are grateful for the opportunity to comment and are eager to help the U.S. lead in this space.”

To view the full press release, visit https://ibn.fm/xb1Xi

About Amesite Inc.

Amesite delivers its scalable, customizable, white-labeled online learning platform to universities, businesses, museums, and government agencies, enabling them to deliver outstanding digital learning. Amesite provides a single system that combines eCommerce, instruction, engagement, analytics, and administration using best-in-class infrastructure to serve multibillion-dollar online learning markets. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Zeeve, a leading web3 infrastructure automation platforms and node-as-a-service provider, is partnering with DigitalOcean to expand its cloud network. Zeeve has added platform-wide support for DigitalOcean, providing users with an even more seamless experience across public and private blockchain protocols. According to the announcement, the partnership will enable users to choose from an array of cloud platforms that are integrated on Zeeve. The company noted that the integration will benefit more than 15,000 developers as well as high-growth startups and other businesses using Zeeve’s platform; the larger web3 ecosystem will also benefit by gaining access to full, archive and validator nodes in minutes through Zeeve Managed Cloud, which is offered by major cloud providers including DigitalOcean, or by configuring their own DigitalOcean cloud account for hosting nodes. The world’s leading cloud platform, DigitalOcean is popular among developers because of its great workflow, dependable network, dynamic provisioning capabilities and affordability. “Our focus at Zeeve is to provide as much flexibility as possible to our users when it comes to the choice of cloud infrastructure to deploy their nodes and networks,” said Zeeve cofounder and CEO Dr. Ravi Chamria in the press release. “DigitalOcean is simple, affordable and offers high-performing compute with predictable pricing, which makes it suitable for startups, and small- to medium-size businesses operating in the web3 space. We have integrated DigitalOcean along with other leading cloud players with Zeeve to offer the most optimized web3 stack where developers can not only deploy nodes on their own DigitalOcean accounts but can also opt for fully managed service from Zeeve.”

To view the full release, visit https://ibn.fm/6UMku

About Zeeve

Zeeve is the leading blockchain Infrastructure as a service platform helping enterprises and blockchain startups build, deploy and manage reliable decentralized apps, blockchain nodes, and networks. Zeeve is a low-code automation platform that is cloud agnostic and supports multiple blockchain protocols with advanced analytics and monitoring of nodes and networks. Zeeve features a powerful set of APIs to build dApps for a plethora of use cases across industries. For more information about the company, please visit www.Zeeve.io.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Nextech (CSE: NTAR) (OTCQB: NEXCF) (FSE: EP2) today announced that it has determined to pursue a direct spinout of its Toggle3D design studio SaaS software platform through a wholly owned subsidiary of the company (“Subco”). It is currently anticipated that the transaction will proceed by way of plan of arrangement pursuant to which the Toggle3D and associated assets will be spun out into a new Subco, subject to final tax and legal structuring considerations. “The spinout of ARway on October 26th has proven to be a tremendously successful way to unlock value for Nextech shareholders. Now we are announcing that we are going to do the same thing with Toggle 3D,” said Evan Gappelberg, CEO of Nextech. “We believe there is a tremendous amount of value currently trapped inside Nextech and these spinouts are aimed at unlocking that value by listing pure play technology companies. We believe that Toggle 3D is now commercially ready with a laser focused team and will be well received by the market. Creating value for Nextech shareholders of which I am the single largest with 10.7mill shares has always been a major focus of mine. This Toggle3D spinout and the possibility of additional future spinouts are intended to unlock the value of the technology that we have been heavily investing in, incubating and building inside Nextech for the last 4-years.”

To view the full press release, visit https://ibn.fm/43r0I

About Nextech AR Solutions Corp.

Nextech is the engine accelerating the growth of the metaverse. Using breakthrough AI, Nextech AR is able to quickly, easily and affordably ARitize (transform) vast quantities and varieties of existing assets at scale making products, people and places ready for interactive 3D use, giving creators at every level all the essential tools they need to build out their digital AR vision in the metaverse. The company’s platform-agnostic tools allow brands, educators, students, manufacturers, creators, and technologists to create immersive, interactive and the most photo-realistic 3D assets and digital environments, compose AR experiences, and publish them omnichannel. With a full suite of end-to-end AR solutions in 3D commerce, education, events, and industrial manufacturing, Nextech AR is in a unique position to meet the needs of the world’s biggest brands and all metaverse contributors. For more information about the company, visit www.NextechAR.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Data443 (OTC: ATDS), a data security and privacy software company, today announced that it has partnered with IBN, a multifaceted financial news and publishing company for private and public entities, to provide corporate communications expertise. Data443 is committed to organizing the world’s information by identifying and protecting sensitive data. The company provides software and services to secure information across devices and databases both at rest and in-transit, locally, on a network or in the cloud. As part of the client partner relationship, IBN will leverage its investor based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs and other outreach tools to generate greater awareness for Data443. “Data security is a fast-growing area within IT, with analysts forecasting sector growth from roughly $19 billion in 2021 to $54.23 billion by 2027. For Data443, that represents a significant opportunity,” said Chris Johnson, director of client solutions for IBN. “We’re excited to customize our comprehensive suite of corporate communications solutions for Data443 as it leverages a privacy-forward methodology and diverse product offerings to address the evolving data security needs of its growing client base.”

To view the full press release, visit https://ibn.fm/FnyKU

About Data443 Risk Mitigation Inc.

Data443 provides data security and privacy management solutions in homes, offices and across enterprises for the multi-cloud. Trusted by over 10,000 business customers, Data443 organizes the world’s data by identifying and protecting sensitive data in various locations, platforms and formats. For more information, visit the company’s website at www.Data443.com.

NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

FE Battery Metals (CSE: FE) (OTCQB: FEMFD) today announced its receipt of an update from SGS metallurgical laboratory, located in Lakefield, Ontario, regarding progress for the ongoing metallurgical testwork on the Augustus Lithium Property. According to the update, the testwork successfully produced a spodumene concentrate with 6.08% lithium oxide (“Li2O”) for the composite samples from the Augustus Property. In addition, the company announced it has closed a non-brokered private placement of 3,707,500 flow-through (“FT”) shares for gross proceeds of $ 2,225,475 by issuing a total of 2,040,000 Quebec FT shares, each at price of $0.625, and 1,667,500 National FT shares, each at a price of $ 0.57. In connection with the private placement, finder’s fees may be paid to eligible parties in accordance with CSE policies. Closing of the proposed private placement is subject to obtaining all required regulatory approvals, including from the CSE.

To view the full press release, visit https://ibn.fm/iCpvv

About FE Battery Metals Corp

FE Battery Metals is focused on identifying, exploring and advancing early-stage lithium pegmatite projects in Canada. The company’s primary efforts have been on exploration projects located in Quebec, with its flagship property being the Augustus Lithium Property. Augustus is located in the immediate vicinity of Val d’Or, Quebec, where several historical prospects and a previously active lithium mine is located within a 10km radius from the property. North American Lithium mine (“NAL”) and Authier are two notable projects in the area that highlight the potential of the Augustus Lithium Property.

NOTE TO INVESTORS: The latest news and updates relating to FEMFD are available in the company’s newsroom at https://ibn.fm/FEMFD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Processa Pharmaceuticals (NASDAQ: PCSA), a diversified clinical-stage company developing products to improve survival and/or the quality of life for patients with unmet medical need conditions, today announced positive top-line results on the clinical symptoms associated with gastroparesis from a 4-week Phase 2A study of PCS12852. The randomized, dose-response study for the treatment of patients with gastroparesis is designed to evaluate the safety, efficacy and pharmacokinetics of two dosage regimens of PCS12852 versus placebo. “This Phase 2A gastroparesis study shows a trend toward an increase in the gastric emptying rate and clinically meaningful improvements in gastroparesis symptoms in patients receiving a 0.5 mg daily dose of PCS12852,” said Dr. Sian Bigora, chief development officer at Processa. “The reduction in clinical symptoms and the continued improvement in the total ANMS GCSI-DD score and multiple individual symptom scores were better for the PCS12852 0.5 mg daily dose group than placebo or the 0.1 mg group. These findings suggest that a longer treatment than 28 days may result in greater differences in the gastroparesis symptoms for the 0.5 mg PCS12852 daily dose group when compared to the placebo dose group. These results, consistent with the previous pre-clinical and clinical studies, give us confidence that dosing 0.5 mg of PCS12852 daily for at least 12 weeks should improve the clinical symptom score more than a placebo treatment.”

To view the full press release, visit https://ibn.fm/pwLEu

About Processa Pharmaceuticals Inc.

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company uses these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently. Active clinical pipeline programs include Next Generation Capecitabine PCS6422 (metastatic colorectal cancer and breast cancer), PCS499 (ulcerative necrobiosis lipoidica) and PCS12852 (GI motility/gastroparesis). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Grom (NASDAQ: GROM), a media, technology and entertainment company dedicated to family friendly programming, web filtering technology and safe social media for kids, has closed its previously announced underwritten public offering of 1,415,682 units at a price to the public of $2.89 per unit and 314,422 pre-funded units at a price to the public of $2.889 per pre-funded unit. Grom secured aggregate gross proceeds of approximately $5.0 million, prior to deducting underwriting discounts, commissions, and other estimated offering expenses. In addition, the company granted the underwriters a 45-day option to purchase up to an additional 259,515 units or pre-funded units solely to cover over-allotments, if any, less underwriting discounts and commissions. On Dec. 12, 2022, the underwriters exercised the option to purchase an additional 495,602 warrants. The company intends to use the net proceeds for general corporate purposes, which may include marketing and advertising, acquisitions and strategic partnerships, research and development of original content and technology, expansion of its intellectual property portfolio by investment, and other working capital and general corporate purposes. EF Hutton Acquisition Corp. (NASDAQ: EFHTU), division of Benchmark Investments LLC, acted as sole book running manager for the offering.

To view the full press release, visit https://ibn.fm/lDz21

About Grom Social Enterprises Inc.

Grom is a growing social media platform and original content provider of entertainment for children under 13 years of age, which provides safe and secure digital environments for kids that can be monitored by their parents or guardians. The company has several operating subsidiaries, including Grom Social, which delivers its content through mobile and desktop environments (web portal and apps) that entertain children, let them interact with friends, access relevant news, and play proprietary games while teaching them about being good digital citizens. The company owns and operates Top Draw Animation, which produces award-winning animation content for some of the largest international media companies in the world. The company owns an 80% stake in Curiosity Ink Media, which is a global media company that develops, acquires, builds, grows and maximizes the short, mid and long-term commercial potential of Kids & Family entertainment properties and associated business opportunities. Grom also includes Grom Educational Services, which has provided web filtering services for K-12 schools, government and private businesses. For more information, please visit the company’s website at https://gromsocial.com or for investor relations information, please visit https://investors.gromsocial.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Cerberus Cyber Sentinel (NASDAQ: CISO), a managed compliance and cybersecurity provider, was spotlighted during a recent Smart Money Circle (“SMC”) episode. During the segment, host Adam Sarhan interviewed David Jemmett, CISO CEO and an expert in cybersecurity, healthcare, compliance and governmental regulations. According to SMC, Jemmett has been intimately involved in designing, building, revamping, and/or managing networks and data centers worldwide. During the interview, Jemmett talked about his 35-year career, which included executive management and technology experience with telecommunications, managed services and cybersecurity consulting services — ultimately leading to him creating Cerberus Cyber Sentinel. Jemmett explained that he started the company as a result of previous clients coming to him, seeking help and advice in a world that was becoming increasingly plagued by cybersecurity issues. “Someone is being hacked every 11 seconds,” said Cerberus Cyber Sentinel CEO David Jemmett during the interview. “Before it was a black box and people were like, it will never happen to me. It’s not a matter of if anymore, it’s a matter of when. I mean, 35% of the traffic on the internet is bots looking for, you know, a penetration point. They’re looking to insert something so they can get into your data. [And] it’s just like the pandemic, if you get infected, you can’t tell right away, and you might infect somebody else  before they figure out you’re sick. And that’s the problem with cyber, is people can’t physically see it and can’t identify it. But it’s like the pandemic, and it spreads very, very quickly.”

To view the full interview, visit https://ibn.fm/0Lg6g

About Cerberus Cyber Sentinel Corp.

Cerberus Sentinel is an industry leader in managed cybersecurity and compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.CerberUSSentinel.com.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel Inc. (OTCQB: SDCH) CEO Brian Haugli was a guest on Newsy Morning Rush to discuss the testimony by Twitter whistleblower Peiter Zatko regarding the company’s data and cybersecurity troubles — and what other U.S. companies and even Twitter users can learn from the company’s experience. During the interview, Haugli called the Twitter situation “troublesome,” as he pointed out the fact that Twitter leadership ignored the concerns that Zatko raised. “Cybersecurity is not an IT risk, it’s an operational risk that really needs to be addressed as an enterprise,” said SideChannel CEO Brian Haugli during the interview. “That means that the CEO, the CFO, even the board, need to take it seriously. They need to be looking at it. Believe it or not, a lot of organizations aren’t at that maturity level, but I would have expected Twitter to have been at that point in their security program to be listening to their chief information security officer, who’s raising risks to them, and then taking action and supporting from the top down how to actually address the deficiencies and gaps that he’s highlighting. . . . We definitely need to have a level of regulation that is both enforceable and taken seriously by the organizations that it’s put on; the government also actually needs to be able to enforce it.”

To view the full interview, visit https://ibn.fm/KglrF

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair, skin and sexual wellness, has been approved to dual list its shares on Upstream beginning Jan. 10, 2023; the ticker symbol will remain JUPW. A revolutionary trading app for digital securities and NFTs, Upstream is powered by Horizon Fintex and MERJ Exchange Limited. The company is inviting global investors to create an account on Upstream and complete a simple KYC identity verification in order to prepare for trading; the Upstream market is open Monday through Friday, 1 a.m. to 9 p.m. EST. According to the announcement, Jupiter anticipates that the dual listing will provide the company with access to a global, digital-first investor base that trades using an array of methods, including USDC digital currency, credit, debit, PayPal and USD; this broader access will unlock liquidity and enhance price discovery while globalizing the opportunity for investors to invest in Jupiter. “Building shareholder value is an ongoing goal of ours,” said Jupiter Wellness CEO Brian John in the press release. “We believe a dual listing on Upstream will expand the ways we reach potential supporters and give us access to innovative new ways to introduce the company to potential shareholders and customers.”

To view the full press release, visit https://ibn.fm/RIFiT

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, eczema, burns and sexual wellness. Revenue is generated through the sales of OTC and consumer products, contract research agreements, and licensing royalties. For additional information about this company, please visit www.JupiterWellnessInc.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, has filed its audited financial statements and is reporting on corporate highlights for the fiscal year ending Aug. 31, 2022. Highlights include the World Intellectual Property Organization publishing TRYPF’s international PCT patent application, which covers the intravenous administration of psilocybin and psilocin. The patent is connected to Tryp’s development of TRP-8803, an intravenous infusion of psilocin designed to significantly reduce the time to onset of the psychedelic state, control the depth and duration of the psychedelic experience, and reduce the overall duration of the intervention to a commercially feasible timeframe. Other highlights include the filing of provisional patents for the use of psilocybin for the treatment of patients with binge eating disorder and for the treatment of patients with fibromyalgia. The report also noted the filing of a provisional patent for crystalline forms of TRP-8803. In addition, Tryp started preparations for a phase 2a trial using TRP-8802 to evaluate psilocybin-assisted therapy among patients with fibromyalgia. “Tryp has continued to execute its multipronged strategy of exploring the clinical utility of psilocybin-assisted psychotherapy, expanding its IP portfolio, and advancing TRP-8803 (IV-infused psilocin), the company’s proprietary and eventual commercial product,” said Tryp Therapeutics CEO Jim Gilligan in the press release. “To that end, Tryp expects to have the interim results from our phase 2a clinical binge eating disorder trial as early as January 2023 and has submitted several provisional patents related to fibromyalgia, binge eating disorder, and co-formers of TRP-8803. Furthermore, the company has completed a series of pharmacology and toxicology programs necessary to advance TRP-8803 into the clinic. With a burgeoning pipeline and a variety of novel and impactful provisional patents in place, we look forward to continuing to execute our business plan in 2023 and beyond.”

To view the full release, visit https://ibn.fm/rqUez

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) for the potential treatment of eating disorders, chronic pain, and other indications. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Cost-cutting becomes a priority for businesses looking to remain strong during record inflation
• “It’s always a question of what to prioritize and which costs to minimize while preserving the quality of your product,” states a Forbes article
• Cerberus ensures that companies not only stay more secure but also build a culture of cybersecurity

In a fragile economy with a possible recession looming on the horizon, savvy companies are taking a close look at ways to tighten their belts. As they do so, a recent Forbes article cautions wise business leaders to keep cybersecurity in the forefront (https://ibn.fm/ui99g), a strategy that Cerberus Cyber Sentinel (NASDAQ: CISO) can help with.

The article details “why cyber protection should become a ‘must-have,’ not a ‘nice-to-have’ in your business decision-making process and why you should prioritize it in times of economic uncertainty.” Titled “Why Businesses Shouldn’t Cut Cybersecurity Costs—Especially During a Crisis,” the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide nutraceuticals, cosmetics, biotherapeutics and food/beverage industries, has shipped its first-ever commercial production lot of an UltraShear nanoemulsion product. The revolutionary product was created and enabled by PBIO’s Ultra Shear Technology(TM) nanoemulsification platform. According to the announcement, the product, which was designed for Safer Medical of Montana (“SMM”), is a CBD oral spray. Earlier this year, PBIO and SMM entered into a multiyear agreement that covers three phases of development and commercialization of a custom-formulated oral spray of hemp-derived nanoemulsified CBD designed for rapid absorption and effectiveness. “This launches a new chapter for Pressure BioSciences, as UltraShear commercialization enters into a phase of scale up and rapid growth,” said Pressure BioSciences director of sales and marketing John B. Hollister in the press release. “PBI has long established itself as an expert in the development and application of extreme high-pressure technology to enable remarkable and important new scientific and production capabilities, but UltraShear now opens an extraordinarily broad range of important and large new commercial application markets, from pharmaceuticals to nutraceuticals, cosmetics, food and beverages, agrochemicals and many more. Black Ops Nano CBD is the first UltraShear product, but vastly more products, far beyond this initial cannabinoid opportunity, will quickly follow.”

To view the full press release, visit https://ibn.fm/gIEc7

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. PBIO’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented-enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control biomolecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of PBIO’s pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Field Trip Health (OTC: FTHWF) (TSX.V: FTHW), a leading standalone psychedelic-assisted therapy business with clinical operations and research facilities in multiple countries, is focused on delivering innovative services to drive the best therapeutic outcomes with one of the most experienced clinical teams in the industry. Through its technology-empowered clinics and apps that are designed to scale globally, the company helps people through an integrated, evidence- based approach to healing and thriving. For more information, visit the company’s websites at https://www.meetfieldtrip.com, https://www.fieldtriphealth.com and https://www.fieldtriphealth.nl.

To join the KCSA Mental Health Investor Conference, visit https://ibn.fm/KCSA2022MentalHealthQ4

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, provides the online investment community with custom-built portals that include summaries on hundreds of presenting companies. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN utilizes social media and syndicated articles to maximize the visibility of various investor conferences.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Filament Health (OTCQB: FLHLF) (NEO: FH) is a clinical-stage natural psychedelic drug development company. The company believes that safe, standardized, naturally derived psychedelic medicines can improve the lives of many, and its mission is to see them in the hands of everyone who needs them as soon as possible. Filament’s platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The company is paving the way with the first-ever natural psychedelic drug candidates. For more information, visit the company’s website at www.filament.health or contact [email protected].

To join the KCSA Mental Health Investor Conference, visit https://ibn.fm/KCSA2022MentalHealthQ4

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, provides the online investment community with custom-built portals that include summaries on hundreds of presenting companies. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN utilizes social media and syndicated articles to maximize the visibility of various investor conferences.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

DSG Global’s (OTCQB: DSGT) wholly owned subsidiary, Vantage Tag Systems, has announced the debut of the V-Club GPS Fleet Management-enabled Fleet Cart at the PGA Merchandise Show in Orlando, Florida, on Jan 24-27, 2023. Designed as a direct alternative to incumbent fleet selections, the V-Club sets new standards for performance, golfer comfort/safety, and affordability. To celebrate the debut, Vantage Tag Systems is giving away two of the new fully outfitted V-Club Luxury fleet golf carts at the PGA show from booth #3433. “I’ve been in this business for over 25 years.” said DSGT CEO Bob Silzer. “With very few changes to the present fleet car, the all-new Vantage V-Club fleet cart is the most complete offering in the industry at a price point that is a new benchmark for golf operators who are looking to enhance their fleet management capabilities, appearance and golfer experience.”

To view the full press release, visit https://ibn.fm/iyfOu

About DSG Global Inc.

DSG Global is an emerging global technology company with an array of interconnecting businesses in some of the fastest-growing market sectors. DSGT has roots in the golf industry, in which it specializes in fleet management with patented analytics, mobile touch screen engagement and electric golf carts under the Vantage Tag Systems (“VTS”) brand.

NOTE TO INVESTORS: The latest news and updates relating to DSGT are available in the company’s newsroom at https://ibn.fm/DSGT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and the Clean Beverage(R) company, today announced that it has added two new direct-store-delivery (“DSD”) partners, C&M Sales and Alber & Leff Foods Company, to cover the entire state of Arkansas and Western Pennsylvania, respectively. With the expansion, Alkaline88(R) has DSD coverage in fourteen states as it continues to grow sales in the convenience and grocery channels. “The addition of two great new DSD partners will help Alkaline88 continue to grow in important regional grocery chains as well as earn shelf space in more of the 150,000 convenience stores in the country,” said Frank Lazaran, president and CEO of The Alkaline Water Company. “In the past year, Alklaine88 has become a top-15 value-added water brand in the convenience channel. According to Nielsen data for the 52 weeks ending Nov. 8, 2022, Alkaline88’s year-over-year sales growth rate in c-stores was nearly 11 times greater than that of the overall category and was the strongest of the other top-30 brands.”

To view the full press release, visit https://ibn.fm/zBUR5

About The Alkaline Water Company

The Alkaline Water Company is the Clean Beverage(R) company making a difference in the water you drink and the world we share. Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for Alkaline88. To purchase The Alkaline Water Company’s products online, visit www.Alkaline88.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel Inc. (OTCQB: SDCH) CEO Brian Haugli was a guest on “Mornings with Maria,” a Fox Business program that features industry titans and economic experts discussing the major news and themes driving the business day and the market moves. Haugli discussed rising concerns that TikTok, an application owned by China-based DanceByte, presents a national security issue. Those concerns have been fueled by GOP leaders calling for the application to be banned and the FBI issuing a statement about the possibility that the Chinese government could use the app to control data collection on millions of users, control the recommendation algorithm or control software on millions of devices. “[TikTok] is an application that runs on your phone, widely popular, but this application has access to things on your phone that you might hold dear,” said SideChannel CEO Brian Haugli during the interview. “Your contacts, your locations, your buying intent, your shopping history, your browser history — everything that you probably want to keep private. That application has access to your phone in a way that could give them access to all of that information. Why it would be considered a national security threat, in my opinion, is that you’re now able to build a profile on every individual who is using that application. You’re able to take that information in aggregate, and in the hands of a foreign national, a foreign party, what could be done, right? . . . We have the opportunity to put pressure on Google and Apple to remove this application from the store. We have the opportunity to build better regulations within the United States and can actually set up infrastructure that could block access to this data or this data leaving our environment. It’s not something that the U.S. has set up today, and it’s something that I think we very much need.”

A provider of cybersecurity services and technology for emerging and middle-market companies, SideChannel also announced that it is partnering with InvestorBrandNetwork (“IBN”) for its corporate communications. IBN is a multifaceted financial news and publishing company for private and public entities. The agreement calls for IBN to leverage its investor-based distribution network of more than 5,000 syndication outlets along with multiple newsletters, social media channels, wire services and blogs to generate greater awareness for SideChannel.

To view the full interview, visit https://ibn.fm/wno68

To view the full press release, visit https://ibn.fm/i8dH4

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the appointment of Marc Malandro, Ph.D., to the company’s scientific advisory board. Dr. Malandro, a highly regarded scientific leader and expert in genomics, molecular biology, biochemistry and bioengineering, will serve alongside other key thought leaders in their respective fields to guide the company’s initiatives and growth strategy. “Marc is not only a very insightful scientist, but he is an equally perceptive and thoughtful innovator. His understanding of the business of science, and the commercial application of novel discovery, is precisely why he is such a valuable scientific advisor,” said Predictive Oncology’s CEO and Board Chairman Raymond F. Vennare. “Marc’s understanding of the depth and breadth of the biopharmaceutical industry is invaluable as we look to build relationships and progress to help accelerate drug discovery and advance drug development.”

To view the full press release, visit https://ibn.fm/Jje9E

About Predictive Oncology Inc.

Predictive Oncology is a knowledge-driven company focused on applying artificial intelligence (“AI”) to develop optimal cancer therapies, which can lead to more effective treatments and improved patient outcomes. Through AI, Predictive Oncology uses a biobank of 150,000+ cancer tumors, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of success. The company offers a suite of solutions for oncology drug development from early discovery to clinical trials. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• SideChannel is a company making cybersecurity accessible and simple, especially for small and mid-sized businesses (“SMBs”)
• The company provides cybersecurity services in the form of virtual CISOs (“vCISOs”), engineering services that enable the vCISOs to provide operational day-to-day security and privacy to clients, and proprietary security software called Enclave
• SideChannel’s differentiator from its competition is its team of experts, and recently the company hired IT and cybersecurity veteran Sean Higgins as Principal Consultant
• In this role, Sean will help client companies’ CISOs and senior management evaluate and have greater levels of confidence in their security programs

SideChannel (OTCQB: SDCH), a company focused on making cybersecurity more accessible and simple, especially for small and mid-sized businesses (“SMBs”), recently expanded its team with the hiring of Sean Higgins as Principal Consultant (https://ibn.fm/AeZGL).

An information technology (“IT”) veteran with over 35 years of experience, almost 30 of which have been focused on cybersecurity, Sean previously worked as the Chief Technology Officer (“CTO”) and Co-Founder at Herjavec Group, a global cybersecurity product and…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, will be presenting live at the VirtualInvestorConferences.com event; the conference is scheduled for Dec. 15, 2022. According to the announcement, Tryp Therapeutics CEO Jim Gilligan will present during the event. Gilligan’s presentation is slated to begin at 2 p.m. ET, and the presentation will include time set aside for a real-time Q&A session.  In addition, company officials will be available for one-on-one meetings with investors on Dec. 16 and Dec. 19–Dec. 20. An archived webcast of the presentation will be available after the event.

To view the full presentation, visit https://ibn.fm/9f503

To view the full release, visit https://ibn.fm/sMa8A

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) for the potential treatment of eating disorders, chronic pain, and other indications. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Mydecine (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address addiction and mental health. The company today announced, further to its Sept. 1 news release, it has closed the sale of all of the issued and outstanding shares of its wholly owned subsidiary, Mindleap Health, to PanGenomic Health Inc., a company listed on the Canadian Stock Exchange (“CSE”). The sale is a significant step towards refocusing Mydecine’s resources on its primary strategy of discovering and developing innovative pharmaceutical psychedelic substances to meet the unmet needs of millions of patients worldwide. “We are extremely proud of what we built with the Mindleap App,” said Josh Bartch, chairman and CEO of Mydecine. “Mindleap fills a necessary void in mental health and gives users the tools they need to improve their overall health and wellbeing. The Mydecine team looks forward to watching the application flourish and grow and will provide support at every step of the way. We spoke with numerous parties when we made the decision to part ways with Mindleap, and ultimately, we decided the team at PanGenomic shared the same vision and had the team and the expertise to take the application to the next level.”

To view the full press release, visit https://ibn.fm/G5qfl

About Mydecine Innovations Group Inc.

Mydecine is a biotechnology company developing the next generation of innovative medications and therapies to address addiction and mental health. The core strategy blends advanced technology with an elaborate infrastructure for drug discovery and development. Mydecine’s dedicated multinational team constantly develops new paths for breakthrough treatment solutions in areas with considerable unmet needs. By collaborating with some of the world’s leading specialists, the company aspires to responsibly speed up the development of breakthrough medications to provide patients with safer and more effective treatment solutions. At the same time, Mydecine’s approach focuses on the next generation of psychedelic medicine by creating innovative compounds with unmatched therapeutic potential through its clinical trial efforts with world-class scientific and regulatory expertise. Founded in 2020, Mydecine is based out of Colorado, USA, with extended offices in Alberta, Canada, and Leiden, Netherlands. For more information about the company, please visit www.Mydecine.com.

NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles (“EV”), today announced that its subsidiary Energica has begun selling its high-performance electric motorcycles in Japan and Australia. Per the announcement, the first batch of motorbikes will arrive in both countries in Q1 2023. “Japan is a key market for us. Energica’s presence in Japan was sealed in August at the eight-hour Suzuka Circuit where our bikes were acclaimed for their performance during the numerous test laps at this prestigious and world-renowned endurance race,” said Livia Cevolini, Energica Motor Company CEO. “Our partnership with Estar & Co. Ltd. in January 2020 has also improved our efforts in developing our Asia-Pacific network.”

To view the full press release, visit https://ibn.fm/CawRK

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: accelerating the commercial adoption of electric vehicles. By bringing together vehicles, charging and financing solutions under one roof, Ideanomics is the one-stop partner needed to simplify the transition to and operation of any EV fleet. For more information about the company, visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sustainable Green Team (OTCQX: SGTM), an emerging provider of environmentally beneficial solutions for preserving natural resources and the municipal waste and recycling industries, will be featured in an upcoming episode of “New to the Street,” a nationally syndicated program. The company is one of five to be showcased on New to the Street’s 415th broadcast, airing at 10:30 p.m. PT on Monday, Dec. 12, 2022, on the Fox Business Network. The Corporate Law Firm segment will feature Anthony L.G., PLLC’s interviews with Laura Anthony, founding partner, and SGTM’s Chief Executive Officer Tony Raynor. A client of Laura Anthony, Raynor explains to viewers the importance of his and his company’s relationship with the firm. SGTM is on a growth trajectory, and Anthony is ensuring that legal compliances are in place for its continued success.

To view the full press release, visit https://ibn.fm/A1WRR

About Sustainable Green Team Ltd.

The Sustainable Green Team is an emerging provider of environmentally beneficial solutions for preserving natural resources and the municipal waste and recycling industries. The company is a wholesale manufacturer and supplier of wood-based mulch and lumber products, primarily in the Midwest, Southeast and Ohio Valley regions. The company also provides arbor care and storm recovery services to municipalities, corporations and consumers, primarily in the southeastern United States. The company plans to expand its operations through organic growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. The company’s customers include governmental, residential and commercial clients. For more information about the company, visit – www.TheSustainableGreenTeam.com.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel Inc. (OTCQB: SDCH) CEO Brian Haugli was a guest on LiveNOW from Fox with host Josh Breslow. During the interview, Haugli and Breslow discussed concerns about TikTok and its potential impact on national security. According to the interview, some are concerned that TikTok, which is owned by a Chinese company called ByteDance, provides the Chinese government with access to its user data; that data can then be used for questionable purposes. The U.S. government is looking at banning TikTok and other Chinese-owned apps based on the possibility of national security issues. “The fact that TikTok is owned by a company. . . that is headquartered in China, and due to how the CCP, Chinese Communist Party, works with or controls the corporations that exist within China, that’s really the cybersecurity issue, or really the national security issue for the United States to take seriously and consider some type of actions on to either curb its usage or its influence on the citizens of the United states,” said SideChannel CEO Brian Haugli during the interview. “The thinking that I would have. . . are that the Chinese government is influencing ByteDance or controlling ByteDance and its ability to monitor what’s happening on phones that have TikTok installed. And that’s where, to me, a risk really exists.”

In the second presentation, Haugli also discussed security issues—this time cybersecurity concerns—in a growing market: cannabis. He pointed out that in states where cannabis has been legalized, several operations within the industry should take a close look at cybersecurity, specifically agricultural, manufacturing and distribution. “All of these within this manufacturing space are now what we have been calling OT, operational technology,” Haugli stated. “And this is an ever-growing concerning area within cybersecurity because these systems are routinely, as we’ve seen, don’t have security built in them. . . an area to really start thinking about.

To view the full presentations, visit https://ibn.fm/ePJFk and https://ibn.fm/nK6I5

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

BioNxt Solutions (CSE: BNXT) (OTCQB: XPHYF) (FSE: 4XT) today announced that it has signed a non-binding term sheet for the acquisition of certain intellectual property assets and rights related to a novel solid oral drug dosage form coating delivery technology. “BioNxt is extremely pleased to expand our technology portfolio with an additional drug delivery platform,” said Hugh Rogers, CEO and director of BioNxt. “This novel coating system could significantly improve oral tablet and capsule drug delivery with more precise and predictable dosing. We see a broad range of potential applications from nutritional supplements and over the counter medications to prescription medications and psychedelic compounds.”

To view the full press release, visit https://ibn.fm/pNiVu

About BioNxt Solutions Inc.

BioNxt Solutions is a bioscience accelerator focused on next-generation drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical production and evaluation, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.

NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at https://ibn.fm/BNXT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Playgon Games (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR), a proprietary SaaS technology company delivering mobile live dealer technology to online gaming operators globally, intends to complete a nonbrokered unsecured convertible debenture private placement of unsecured convertible debentures and shares for debt transaction. According to the announcement, the gross proceeds of the placement would total up to C$5 million. The announcement noted that the debentures will mature 24 months following the closing of the offering with each $1,000 debenture bearing simple interest at 10% per annum; actual payment amount will be calculated semiannually on the last day of June and December each year. Playgon expects the closing of the offering to happen as soon as possible; the closing is subject to the approval of the TSX.V as well customary closing conditions for private placements. The company plans to use the net proceeds to fund ongoing sales and marketing efforts, specifically in key European jurisdictions, expansion into new markets including Latin America and North America; funds may also be used for ongoing development costs and to launch new proprietary table game content along with general working capital and corporate purposes.

To view the full press release, visit https://ibn.fm/IWQyD

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Playgon’s current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, Playgon products are ideal turnkey solutions for online casinos, sportsbook operators, land-based operators, media groups and big database companies. For more information about the company, please visit www.Playgon.com. 

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork